Gene Query: UAP1L1

Dataset Description Geneva Score
Hepatitis C virus functionally sequesters miR-122 69.34
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 69.34
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 57.91
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 56.19
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 53.77
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 53.38
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 47.79
RNAseq Analysis in glioblastoma cells treated with Mepazine 47.23
Human HAP1 cells before and after nutrient deprivation 43.77
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 43.77
Paxillin regulates genomic networks in prostate cancer [LNCaP] 35.63
Human embryonic stem cells in E8 and AKIT culture medium 34.01
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 34.01
Gene expression in GBM with Cav3.2 inhibition 32.12
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 31.6
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 31.35
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 31.12
Crizotinib v. DMSO in SW480 cells 31.02
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 28.23
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 27.47
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 27.15
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 26.18
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 26.18
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 26.02
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 24.85
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 24.81
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 24.27
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 23.97
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 23.58
Transcriptome analysis in Neobractatin treated cells 23.55
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 23.34
AMPK signaling for naïve pluripotency 22.75
AMPK signaling for naïve pluripotency [Hs] 22.75
ZIKV infection of monocytes activates inflammasome pathways 21.7
RNA-seq in transgenic cells 21.33
RNA-seq analysis of uveal melanoma cells treated with FR900359 20.63
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 20.08
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 20.08
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 19.51
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 19.4
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 19.32
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 18.81
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 18.81
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 18.72
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 18.18
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 18.18
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 17.73
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 17.73
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 17.66
AR-independent prostate cancer is sustained through FGF signaling 16.92
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 16.76
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 16.42
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 16.32
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 16.27
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 15.99
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 15.91
Tumor exosome integrins determine organotropic metastasis 15.84
Gene expression changes upon drug withdrawal (Mel888 cell line) 15.67
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 15.64
Chromatin-informed inference of transcriptional programs in gynecologic cancers 15.31
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 15.31
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 15.1
Controlling for gene expression changes in transcription factor protein networks. 15.1
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 15.07
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 15.07
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 14.77
Small-molecule targeting of brachyury transcription factor addiction in chordoma 14.72
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 14.59
Energy Metabolism during Anchorage-Independence 14.5
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 14.45
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 14.37
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 14.37
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 14.3
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 14.29
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 14.11
Gene expression analysis in response to hypoxic pathway inhibition 13.9
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 13.88
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 13.81
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 13.77
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 13.77
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 13.73
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 13.73
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 13.54
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 13.47
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 13.09
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 12.89
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 12.81
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 12.72
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 12.63
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 12.54
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 12.5
Paxillin regulates genomic networks in prostate cancer [PC3] 12.24
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 12.21
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 12.2
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 12.15
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 12.1
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 12.06
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 12.04
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 12.04
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 12.03
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 12.01
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 11.84
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 11.67
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 11.67
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 11.64
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 11.64
RNA-seq of human fibroblasts after irradiation 11.55
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 11.49
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 11.37
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 11.25
circRNA profile in hypopharyngeal cancer 11.13
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 11.11
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 11.08
IRF1 regulates IFN dependent and independent gene expression 11.05
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 11.03
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 10.96
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 10.89
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 10.68
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 10.58
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 10.57
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 10.44
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 10.42
Effects of rFVIIIFc on human macrophages 10.4
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 10.36
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 10.35
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 10.29
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 10.19
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 10.19
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 10.19
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 9.95
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 9.83
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 9.8
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 9.71
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 9.7
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 9.7
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 9.66
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 9.6
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 9.58
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 9.53
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 9.51
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 9.5
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 9.49
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 9.48
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 9.48
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 9.42
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 9.36
SUV420H2 knockdown in PANC-1 9.33
Ro60-knockout cells 9.28
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 9.27
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 9.24
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 9.19
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 9.17
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 9.09
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 9.08
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 9.08
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 9.06
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 9.03
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 8.98
Transcriptome of Stabilin-1 siRNA transfected human monocytes 8.89
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 8.88
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 8.86
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 8.86
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 8.85
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 8.77
Pharmacologic inhibition of STAT5 in AML 8.68
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 8.65
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 8.6
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 8.56
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 8.56
RNA-Seq with and without RNase treatment in PCa cell lines 8.49
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 8.48
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 8.45
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 8.45
Proteomics identifies a marker signature of MAPKi resistance in melanoma 8.38
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 8.26
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 8.22
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 8.15
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 8.13
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 8.1
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 8.09
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 8.06
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 8.05
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 8.02
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 8.02
Genetic-to-epigenetic Therapy for Pancreatic Cancer 8.02
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 8.01
Gene expression changes in human melanoma cell lines compared to primary melanocytes 7.96
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 7.95
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 7.92
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 7.92
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 7.88
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 7.87
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 7.87
Generation of trichogenic adipose-derived stem cells by expression of three factors 7.85
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 7.76
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 7.76
Active translatome profiling with RiboLace in MCF7 cells 7.71
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 7.68
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 7.68
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 7.65
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 7.64
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 7.59
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 7.59
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 7.59
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 7.56
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 7.51
mRNA expression profile of Lymphocytes by high-throuput sequencing 7.48
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 7.45
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 7.42
EWSR1 influences alternative splicing through direct and indirect mechanisms 7.38
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 7.35
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 7.34
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 7.27
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 7.25
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 7.22
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 7.14
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 7.13
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 7.12
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 7.1
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 7.08
Generation and functional characterization of MDSC-like cells 7.04
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 6.95
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 6.91
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 6.91
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 6.8
MicroRNA targetome analysis during HCMV infection 6.78
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 6.73
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 6.72
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 6.72
RNA sequencing of BT142 and TS603 cell lines 6.7
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 6.7
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 6.7
Ebola virus (EBOV) infection of ARPE-19 cells 6.7
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 6.7
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 6.64
Genome-wide functional assessment of enhancer activities in the human genome 6.62
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 6.6
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 6.6
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 6.59
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 6.55
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 6.51
RNAseq Study in CC-671 Treated Cal-51 Cells 6.51
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 6.49
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 6.49
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 6.48
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 6.45
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 6.44
A sister of NANOG regulates genes expressed in pre-implantation human development 6.42
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 6.37
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 6.36
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 6.36
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 6.36
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 6.36
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 6.36
Global analysis of alternative splicing regulated by RBM10 6.35
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 6.31
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 6.3
Regionally specified human pluripotent stem cell-derived astrocytes 6.28
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 6.27
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 6.22
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 6.2
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 6.15
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 6.07
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 6.06
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 6.01
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 6.01
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 5.98
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 5.86
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 5.85
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 5.82
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 5.82
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 5.81
Irf9 function in immunity in mouse 5.7
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 5.7
A20 regulates canonical wnt-signaling through an interaction with RIPK4 5.66
Nutritional control of protein translation 5.61
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 5.59
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 5.58
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 5.54
Identification of long noncoding RNAs in T-ALL cell lines 5.54
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 5.48
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 5.44
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 5.44
Gene expression changes after LOC550643 silencing 5.43
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 5.38
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 5.33
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 5.31
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 5.29
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 5.28
RNA-seq differential expression studies: more sequence, or more replication? 5.26
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 5.22
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 5.22
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 4.93
Overexpression of NFIB and YBX1 in MCF-7 cells 4.93
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 4.86
NAPRT activation of macrophages 4.84
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 4.81
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 4.75
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 4.7
Global Mapping of Human RNA-RNA Interactions 4.69
snRNAs as regulators of alternative splicing 4.67
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 4.66
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 4.56
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 4.42
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 4.42
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 4.41
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 4.4
Regulating Interleukin-2 activity with engineered receptor signaling clamps 4.39
Gene expression analysis upon mtDNA depletion 4.34
Gene expression analysis upon mtDNA depletion [RNA-seq] 4.34
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 4.3
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 4.26
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 4.23
Paxillin regulates genomic networks in prostate cancer [C4-2] 4.21
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 4.2
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 4.2
The effect of insulin on mRNA transcription of human pluripotent stem cells 4.19
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 4.16
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 4.14
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 4.14
Cell responses to dysregulated VZV-induced cell-cell fusion 4.09
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 4.09
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 4.07
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 4.06
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 4.05
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 4.05
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 4.0
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 3.96
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 3.96
BASP1 modifies the Tamoxifen response 3.96
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 3.94
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 3.88
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 3.86
RNA-seq of naive and primed ES cells 3.84
Regulation of poly(A) tail and translation during the somatic cell cycle 3.82
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 3.81
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  3.76
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 3.75
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 3.69
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 3.69
Transcriptome wide analysis of classically and alternatively activated macrophages 3.66
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 3.66
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 3.62
Identification of long noncoding RNAs regulated by p53 3.6
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 3.59
Molecular Criteria for Defining the Naive Human Pluripotent State 3.58
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 3.51
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.34
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 3.33
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.33
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 3.33
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 3.23
quanTIseq: quantifying immune contexture of human tumors 3.18
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 3.11
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 3.03
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 3.03
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 2.98
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 2.96
Survival of pancreatic cancer cells lacking KRAS function 2.87
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 2.85
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 2.85
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 2.82
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 2.67
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 2.66
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 2.64
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 2.64
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 2.64
Characterization of parental and rociletinib-resistant derived H1975 cell lines 2.5
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 2.49
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 2.48
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 2.48
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 2.47
Downregulation of DDX5/DDX17 and REST 2.45
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 2.44
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 2.43
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 2.41
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 2.41
TFAP2C signalling in human fibroblasts 2.36
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 2.3
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 2.29
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 2.19
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 2.13
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 2.1
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 2.09
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 2.08
circRNA-sequencing 2.07
Random mono-allelic expression in MECP2-mutated cells 2.07
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 2.03
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.03
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.03
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 2.02
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.02
RNA Seq of HMVEC under hypoxia 1.98
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 1.98
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 1.96
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 1.92
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 1.92
Primary Human B-cell Temporal Response to CD40L Stimulation 1.91
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 1.91
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.9
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.9
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 1.88
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 1.88
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 1.84
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 1.79
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 1.75
CHD1 regulates cell fate determination by activation of differentiation-induced genes 1.75
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 1.73
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.73
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.73
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.62
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 1.58
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 1.56
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.54
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 1.53
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 1.52
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 1.51
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 1.49
Efficient derivation of microglia-like cells from human pluripotent stem cells 1.49
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.48
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 1.47
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 1.46
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 1.44
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.44
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 1.42
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 1.42
Macrophage Ad5f35 PhenoMap 1.4
miRNAs affected by antagomiR-17 treatment 1.37
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 1.33
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 1.33
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 1.32
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 1.31
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 1.3
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.18
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 1.14
The pioneer factor CEBPA modulates vitamin D signaling 1.12
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 1.12
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.09
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 1.08
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 1.08
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.07
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 1.05
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 1.0
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 0.99
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 0.99
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.97
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 0.97
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 0.96
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 0.95
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.95
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 0.92
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.89
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.83
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 0.8
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.8
PRDM1 inhibits proliferation of human colon cancer organoids 0.78
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.76
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.72
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 0.69
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.67
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 0.66
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.65
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.63
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.62
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.62
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.61
MHC Transcriptomic landscape at haplotype-specific resolution 0.61
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.56
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 0.54
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 0.53
Primate transcript and protein expression levels evolve under compensatory selection pressures 0.47
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.47
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 0.46
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.4
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.37
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.36
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.34
Gene expression analysis of breast cancer cell-lines 0.34
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.34
Transcriptomic analysis of human macrophages in 3D 0.33
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.3
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 0.28
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 0.2
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.2
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 0.18
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.18
The role of m6A/m-RNA methylation in stress response regulation 0.18
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 0.17
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 0.17
Proliferation-correlated expression 0.17
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.17
CD74 role in transcription regulation 0.16
CD74 role in transcription regulation [RNA-seq] 0.16
RNA sequencing of GlyH-101-treated MCF-7 cell line 0.13
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.12
Discovering human diabetes-risk gene function with genetics and physiological assays 0.11
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 0.05
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.04
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.04
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation